PortfoliosLab logo

Akero Therapeutics, Inc. (AKRO)

Equity · Currency in USD · Last updated Nov 28, 2022

Company Info

ISINUS00973Y1082
CUSIP00973Y108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$45.39
Year Range$8.00 - $45.74
EMA (50)$36.72
EMA (200)$24.44
Average Volume$751.60K
Market Capitalization$2.05B

AKROShare Price Chart


Loading data...

AKROPerformance

The chart shows the growth of $10,000 invested in Akero Therapeutics, Inc. in Jun 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $25,022 for a total return of roughly 150.22%. All prices are adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%JuneJulyAugustSeptemberOctoberNovember
430.58%
-2.56%
AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

AKROCompare to other instruments

Search for stocks, ETFs, and funds to compare with AKRO

AKROReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M4.35%4.33%
6M453.62%-0.78%
YTD116.74%-15.53%
1Y106.67%-14.36%
5Y30.59%9.43%
10Y30.59%9.43%

AKROMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-17.16%1.20%-19.97%-26.07%-17.64%9.38%8.36%14.75%189.79%24.11%8.47%
202114.03%3.33%-4.57%6.17%-15.00%-5.23%-13.58%10.73%-5.86%-3.85%-1.07%-0.52%
202011.24%-11.83%-2.62%-3.77%24.61%-1.97%40.89%-7.15%-5.55%-13.77%8.40%-10.35%
20194.53%26.37%14.50%-17.90%2.02%-15.17%12.72%

AKROSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Akero Therapeutics, Inc. Sharpe ratio is 0.68. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.50JuneJulyAugustSeptemberOctoberNovember
0.68
-0.60
AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

AKRODividend History


Akero Therapeutics, Inc. doesn't pay dividends

AKRODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember0
-16.06%
AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

AKROWorst Drawdowns

The table below shows the maximum drawdowns of the Akero Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Akero Therapeutics, Inc. is 79.96%, recorded on Jun 1, 2022. It took 93 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.96%Jul 10, 2020478Jun 1, 202293Oct 13, 2022571
-57.16%Aug 29, 2019139Mar 18, 202073Jul 1, 2020212
-14.83%Jun 27, 20199Jul 10, 20192Jul 12, 201911
-13.27%Oct 25, 202210Nov 7, 20226Nov 15, 202216
-9.04%Jul 29, 20192Jul 30, 20196Aug 7, 20198
-8.22%Jun 24, 20192Jun 25, 20191Jun 26, 20193
-7.35%Aug 8, 20192Aug 9, 20198Aug 21, 201910
-4.22%Jul 18, 20191Jul 18, 20192Jul 22, 20193
-4.18%Oct 14, 20221Oct 14, 20222Oct 18, 20223
-4.09%Nov 17, 20224Nov 22, 20222Nov 25, 20226

AKROVolatility Chart

Current Akero Therapeutics, Inc. volatility is 48.94%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%500.00%JuneJulyAugustSeptemberOctoberNovember
48.94%
12.31%
AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)